Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

DexTech Medical

5.2

 

SEK

 

+6.12 %

Less than 1K followers

DEX

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

Overview
Ownership
Investor consensus
Compare
+6.12%
+28.08%
+25%
+30%
+27.45%
+23.22%
-21.21%
-91.8%
-46.51%

DexTech Medical is a biotechnology research company. Today specialisation is in the area of urologic oncology, where common diseases include prostate cancer. A significant part of the research is carried out in collaboration with international players, research institutes and universities. The company was established in 2004 and is based in Uppsala.

Read more
Market cap
96.13M SEK
Turnover
22.36K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Financial calendar
30/8
2025

Annual report '25

3/11
2025

Interim report Q1'26

4/11
2025

General meeting '25

All
Press releases
ShowingAll content types
Regulatory press release5/19/2025, 9:20 AM

DexTech Medicals patentansökan avseende GMP tillverkning av OsteoDex är godkänd

DexTech Medical
Regulatory press release5/19/2025, 9:20 AM

DexTech Medical's patent application regarding GMP manufacturing of OsteoDex is approved

DexTech Medical
Regulatory press release4/29/2025, 9:15 AM

DexTech Medical AB, Delårsrapport 1 juli, 2024 - 31 mars 2025

DexTech Medical

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release4/29/2025, 9:15 AM

DexTech Medical AB Interim report July 1, 2024 - March 31, 2025

DexTech Medical
Regulatory press release4/23/2025, 8:05 AM

DexTech Medical's myeloma study, strong follow-up results

DexTech Medical
Regulatory press release4/23/2025, 8:05 AM

DexTech Medicals myelom studie, starka uppföljningsresultat

DexTech Medical
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team